Standard

Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia. / Osipova, N.A.; Niauri, D.A.; Gzgzyan, A.M.; Dzhemlikhanova, L.Kh.

в: Вестник Санкт-Петербургского государственного университета. Серия 11. Медицина, Том 12, № 2, 2017, стр. 161-169.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Osipova, NA, Niauri, DA, Gzgzyan, AM & Dzhemlikhanova, LK 2017, 'Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia', Вестник Санкт-Петербургского государственного университета. Серия 11. Медицина, Том. 12, № 2, стр. 161-169.

APA

Osipova, N. A., Niauri, D. A., Gzgzyan, A. M., & Dzhemlikhanova, L. K. (2017). Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia. Вестник Санкт-Петербургского государственного университета. Серия 11. Медицина, 12(2), 161-169.

Vancouver

Osipova NA, Niauri DA, Gzgzyan AM, Dzhemlikhanova LK. Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia. Вестник Санкт-Петербургского государственного университета. Серия 11. Медицина. 2017;12(2):161-169.

Author

Osipova, N.A. ; Niauri, D.A. ; Gzgzyan, A.M. ; Dzhemlikhanova, L.Kh. / Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia. в: Вестник Санкт-Петербургского государственного университета. Серия 11. Медицина. 2017 ; Том 12, № 2. стр. 161-169.

BibTeX

@article{5d563c3989ab4db49b228809a276caf6,
title = "Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia",
abstract = "The purpose of this study was to evaluate the clinical efficiency of desmopressine and diclofenac in incontinent patients with nocturnal polyuria and polyuria. A total of 277 patients ≥18 ≤ 55 years of age with complaints of urinary incontinence were included. 143 women had stress incontinence, 43 - urge incontinence and 91 - mixed incontinence. The overall prevalence of nocturia was 34.7 ± 2.9% (96 women). The frequency of poliuriya was 7 ± 2.1 % in stress incontinence, 11.6 ± 4.9 % in urge incontinence and 9.9 ± 3.1 % in mixed incontinence (p > 0.05). The frequency of nocturnal polyuria was 17.5 ± 3.2% in stress incontinence, 27.9 ± 6.8% in urge incontinence and 25.3 ± 4.6 % mixed incontinence (p > 0.05). Patients were randomized to receive either desmopressin or diclofenac in a double - blind fashion. The statistically significant recovery of renal function occurred in 8 incontinent women with polyuria and 19 with nocturnal polyuria who received diclofenac and in 12 incontinent women with polyuria and 18 with nocturnal polyuria who received desmopressin (Minirin). Refs 5. Figs 12. Table 1.",
keywords = "RENAL OSMOREGULATOIN FUNCTION, INCONTINENCE, SODIUM EXCRETION, DESMOPRESSIN, Diclofenac",
author = "N.A. Osipova and D.A. Niauri and A.M. Gzgzyan and L.Kh. Dzhemlikhanova",
year = "2017",
language = "English",
volume = "12",
pages = "161--169",
journal = " ВЕСТНИК САНКТ-ПЕТЕРБУРГСКОГО УНИВЕРСИТЕТА. МЕДИЦИНА",
issn = "1818-2909",
publisher = "Издательство Санкт-Петербургского университета",
number = "2",

}

RIS

TY - JOUR

T1 - Correction of renal function by desmopressin and diclofenac in incontinent women with nocturia

AU - Osipova, N.A.

AU - Niauri, D.A.

AU - Gzgzyan, A.M.

AU - Dzhemlikhanova, L.Kh.

PY - 2017

Y1 - 2017

N2 - The purpose of this study was to evaluate the clinical efficiency of desmopressine and diclofenac in incontinent patients with nocturnal polyuria and polyuria. A total of 277 patients ≥18 ≤ 55 years of age with complaints of urinary incontinence were included. 143 women had stress incontinence, 43 - urge incontinence and 91 - mixed incontinence. The overall prevalence of nocturia was 34.7 ± 2.9% (96 women). The frequency of poliuriya was 7 ± 2.1 % in stress incontinence, 11.6 ± 4.9 % in urge incontinence and 9.9 ± 3.1 % in mixed incontinence (p > 0.05). The frequency of nocturnal polyuria was 17.5 ± 3.2% in stress incontinence, 27.9 ± 6.8% in urge incontinence and 25.3 ± 4.6 % mixed incontinence (p > 0.05). Patients were randomized to receive either desmopressin or diclofenac in a double - blind fashion. The statistically significant recovery of renal function occurred in 8 incontinent women with polyuria and 19 with nocturnal polyuria who received diclofenac and in 12 incontinent women with polyuria and 18 with nocturnal polyuria who received desmopressin (Minirin). Refs 5. Figs 12. Table 1.

AB - The purpose of this study was to evaluate the clinical efficiency of desmopressine and diclofenac in incontinent patients with nocturnal polyuria and polyuria. A total of 277 patients ≥18 ≤ 55 years of age with complaints of urinary incontinence were included. 143 women had stress incontinence, 43 - urge incontinence and 91 - mixed incontinence. The overall prevalence of nocturia was 34.7 ± 2.9% (96 women). The frequency of poliuriya was 7 ± 2.1 % in stress incontinence, 11.6 ± 4.9 % in urge incontinence and 9.9 ± 3.1 % in mixed incontinence (p > 0.05). The frequency of nocturnal polyuria was 17.5 ± 3.2% in stress incontinence, 27.9 ± 6.8% in urge incontinence and 25.3 ± 4.6 % mixed incontinence (p > 0.05). Patients were randomized to receive either desmopressin or diclofenac in a double - blind fashion. The statistically significant recovery of renal function occurred in 8 incontinent women with polyuria and 19 with nocturnal polyuria who received diclofenac and in 12 incontinent women with polyuria and 18 with nocturnal polyuria who received desmopressin (Minirin). Refs 5. Figs 12. Table 1.

KW - RENAL OSMOREGULATOIN FUNCTION

KW - INCONTINENCE

KW - SODIUM EXCRETION

KW - DESMOPRESSIN

KW - Diclofenac

UR - https://www.elibrary.ru/item.asp?id=29866434

M3 - Article

VL - 12

SP - 161

EP - 169

JO - ВЕСТНИК САНКТ-ПЕТЕРБУРГСКОГО УНИВЕРСИТЕТА. МЕДИЦИНА

JF - ВЕСТНИК САНКТ-ПЕТЕРБУРГСКОГО УНИВЕРСИТЕТА. МЕДИЦИНА

SN - 1818-2909

IS - 2

ER -

ID: 76578461